Eight Roads
Deal focus: China big data player goes global
China’s Kyligence is plugging new technologies into an increasingly cloud-based and services-oriented enterprise software space. It has raised $70 million to pump up an international expansion
Sequoia joins $25m Series D for Singapore's StashAway
Sequoia Capital India has joined a S$33.3 million ($25 million) Series D round for Singapore-based wealth management platform StashAway.
China data analytics start-up Kyligence raises $70m
Kyligence, a China-based data analytics business, has closed a $70 million Series D round led by SPDB International.
Prosus, TPG lead $350m round for India pharmacy player
Prosus Ventures and TPG Growth have co-led a $350 million Series E round for India’s API Holdings, best known as the parent of pharmacy portal PharmEasy.
Hillhouse, Tencent lead Series C for China's Fenbeitong
Hillhouse Capital and Tencent Holdings have led a $92.5 million Series C round for Fenbeitong, a China-based enterprise payment and expense management software provider.
China's Cloopen, Adagene complete strong US IPOs
Cloud services provider Cloopen and biotech developer Adagene, both backed by Sequoia Capital China, have raised a combined $460 million in their US IPOs.
China's Pony.ai hits $5.3b valuation with OTPP-led round
Canada’s Ontario Teachers’ Pension Plan Board (OTTP) has led a $267 million Series C round for Chinese autonomous driving technology supplier Pony.ai at a post-money valuation of $5.3 billion.
Eight Roads adds healthcare partner in China
Eight Roads Ventures has recruited Xin Liu, formerly of Greater Pacific Capital, as a partner in its China team.
BA Capital raises $147m for renminbi fund, hits first close on dollar fund
BA Capital, a Shanghai-based venture capital firm also known as Black Ant Capital, has raised RMB1 billion ($147 million) for its second renminbi-denominated fund.
Australia's Square Peg backs Singapore wealth manager
Australian VC firm Square Peg Capital has led a $16 million Series C round for StashAway, a Singapore-based digital financial services provider focused on retail wealth management.
Ocumension climbs on debut after $184m Hong Kong IPO
Ocumension Therapeutics, a Chinese drug developer targeting eye diseases that counts Boyu Capital and Temasek Holdings among its backers, posted a 152% gain on debut following a HK$1.5 billion ($200 million) Hong Kong IPO.
Quan leads $80m Series A for China biotech player
Healthcare-focused VC firm Quan Capital has led an $80 million Series A round for Citrine Medicine, a Chinese biotech developer set up by Eight Roads, F-Prime Capital, and Vivo Capital.
Microsoft venture arm leads Series D for India's FarEye
FarEye, an Indian logistics platform, has raised $25 million in a Series D round led by M12, Microsoft's corporate venture arm.
China office decorating start-up gets Eight Roads backing
InDeco, a Chinese startup that offers one-stop commercial workspace decoration solutions, has raised $20 million in a Series C round led by Eight Roads Ventures.
Eight Roads hires new India venture partner
Eight Roads, an independent investment firm backed by Fidelity International, has appointed pharmaceutical industry veteran Shirish Belapure as a venture partner in its India office.
Eight Roads invests in Indian mobile marketing platform
MoEngage, an India and US-focused business that helps corporate clients improve mobile engagement with consumers, has received $25 million in Series C funding led by Eight Roads.
AVCJ Awards 2019: Exit of the Year - IPO: Innovent Biologics
Innovent Biologics has set a new standard for Chinese biotech, securing an innovative drug development tie-up with Eli Lilly and then completing a successful Hong Kong listing
India's Shadowfax receives $60m Series D
Indian last-mile delivery and logistics start-up Shadowfax has raised $60 million in Series D funding from a group including Eight Roads Ventures and Qualcomm Ventures.
Chinese cancer database provider secures $140m
Medbanks, a Chinese oncology database platform, has raised around RMB1 billion ($140 million) in an extended Series D funding round led by Tencent Holdings and Wu Capital.
PE-backed Chinese SaaS player pursues US IPO
CDP, a Chinese human resources software-as-a-service (SaaS) platform that counts NASDAQ-listed 51job and China Broadband Capital (CBC) as its largest external investors, has filed for an IPO in the US.
Japan's Paidy secures $143m in funding
Paidy, one of Japan’s largest financial technology start-ups, has confirmed $143 million in new funding, comprising an extended Series C round and debt financing.
Qiming leads $37m round for Hong Kong biotech player
Qiming Venture Partners has led a $37 million Series B round for Insilico Medicine, a Hong Kong-based drug development company that uses artificial intelligence (AI).
Fidelity plans Eight Roads demerger
Fidelity International has announced plans to spin-out its proprietary investment arm Eight Roads within the year pending regulatory and shareholder approvals.
Eight Roads appoints Southeast Asia head
Eight Roads Ventures, the proprietary investment arm of Fidelity International, has named Dave Ng as its head of Southeast Asia based in Singapore.